1.
Reasons of treatment switching from first generation to second and third generations of TKIs among CML patients in Iraq -Kurdistan region from 2014-2024. JOC [Internet]. 2025 Oct. 6 [cited 2025 Dec. 7];24(8s):360-8. Available from: https://carcinogenesis.com/index.php/JOC/article/view/1265